Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the market will not be slowing anytime soon — particularly in the U.S. The “Market Estimates and Trend Analysis: Breast Imaging Market” report by Grand View Research projects the global breast imaging market will reach a value of $7.3 billion by 2024.

This is the GE Healthcare Discovery RF Gen 2 system displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting.

Precision can have an enormous impact on patients.

November 7, 2018 — Artificial intelligence (AI) tools trained to detect pneumonia on chest X-rays suffered significant decreases in performance when tested on data from outside health systems, according to a new study.

Greg Freiherr

Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical turf is sports medicine.

PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical turf is sports medicine.

If ongoing clinical studies validate early results, patients whose ACLs have been surgically repaired could be among the first to benefit. Others may include patients with other orthopedic injuries, as well as head trauma victims suspected of having concussions.

Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared to X-ray radiation therapy according to a new study. The study was presented at the recent American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Texas, and the International Society of Pediatric Neuro-Oncology Annual Meeting, June 29-July 3 in Denver.

An enhanced patient experience can reduce providers’ exposure to liability, increase care compliance and positively impact providers’ reputations in the care community.

Two unrelenting forces are on a crash-course in healthcare: The rising volume of patient out-of-pocket payments and increasing patient demands for personalized engagement.

We can debate causality — whether a series of events makes others occur; if events just “happen;” or if conditions made their happening inevitable.

Siemens Healthineers announced the U.S. Food and Drug Administration (FDA) clearance of the Cios Spin, a new mobile C-arm that delivers precise 3-D images for intraoperative quality assurance.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now